Your browser doesn't support javascript.
loading
Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: Results from the infivar network.
Garza-González, Elvira; Bocanegra-Ibarias, Paola; Bobadilla-Del-Valle, Miriam; Ponce-de-León-Garduño, Luis Alfredo; Esteban-Kenel, Verónica; Silva-Sánchez, Jesus; Garza-Ramos, Ulises; Barrios-Camacho, Humberto; López-Jácome, Luis Esaú; Colin-Castro, Claudia A; Franco-Cendejas, Rafael; Flores-Treviño, Samantha; Morfín-Otero, Rayo; Rojas-Larios, Fabian; Mena-Ramírez, Juan Pablo; Fong-Camargo, María Guadalupe; Morales-De-la-Peña, Cecilia Teresita; García-Mendoza, Lourdes; Choy-Chang, Elena Victoria; Aviles-Benitez, Laura Karina; Feliciano-Guzmán, José Manuel; López-Gutiérrez, Eduardo; Gil-Veloz, Mariana; Barajas-Magallón, Juan Manuel; Aguirre-Burciaga, Efren; López-Moreno, Laura Isabel; Martínez-Villarreal, Rebeca Thelma; Canizales-Oviedo, Jorge Luis; Cetina-Umaña, Carlos Miguel; Romero-Romero, Daniel; Bello-Pazos, Fidencio David; Barlandas-Rendón, Nicolás Rogelio Eric; Maldonado-Anicacio, Joyarib Yanelli; Bolado-Martínez, Enrique; Galindo-Méndez, Mario; Perez-Vicelis, Talia; Alavez-Ramírez, Norma; Méndez-Sotelo, Braulio J; Cabriales-Zavala, Juan Francisco; Nava-Pacheco, Yirla Citlali; Moreno-Méndez, Martha Irene; García-Romo, Ricardo; Silva-Gamiño, Aldo Rafael; Avalos-Aguilera, Ana María; Santiago-Calderón, María Asunción; López-García, Maribel; Velázquez-Acosta, María Del Consuelo; Cobos-Canul, Dulce Isabel; Vázquez-Larios, María Del Rosario; Ortiz-Porcayo, Ana Elizabeth.
Affiliation
  • Garza-González E; Hospital Universitario Dr. José E. González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
  • Bocanegra-Ibarias P; Hospital Universitario Dr. José E. González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
  • Bobadilla-Del-Valle M; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico.
  • Ponce-de-León-Garduño LA; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico.
  • Esteban-Kenel V; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico.
  • Silva-Sánchez J; Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.
  • Garza-Ramos U; Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.
  • Barrios-Camacho H; Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.
  • López-Jácome LE; Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México, Mexico.
  • Colin-Castro CA; Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México, Mexico.
  • Franco-Cendejas R; Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México, Mexico.
  • Flores-Treviño S; Hospital Universitario Dr. José E. González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
  • Morfín-Otero R; Hospital Civil de Guadalajara E Instituto de Patología Infecciosa, Guadalajara, Jalisco, Mexico.
  • Rojas-Larios F; Hospital Regional Universitario de Colima, Colima, Colima, Mexico.
  • Mena-Ramírez JP; Hospital General de Zona 21 Tepatitlán De Morelos, Centro Universitario de los Altos (CUALTOS), Universidad de Guadalajara, Tepatitlán de Morelos, Jalisco, Mexico.
  • Fong-Camargo MG; Hospital General Regional No. 1, Chihuahua, Chihuahua, Mexico.
  • Morales-De-la-Peña CT; Hospital General con Especialidades Juan María de Salvatierra, La Paz, Baja California Sur, Mexico.
  • García-Mendoza L; Hospital Angeles Valle Oriente, Monterrey Nuevo León, Mexico.
  • Choy-Chang EV; Hospital General de Zona No. 1, Tapachula, Chiapas, Mexico.
  • Aviles-Benitez LK; Hospital Infantil de Morelia, Morelia, Michoacán, Mexico.
  • Feliciano-Guzmán JM; Hospital de Especialidades Pediátricas de Chiapas, Tuxtla Gutiérrez, Chiapas, Mexico.
  • López-Gutiérrez E; Hospital Regional de Alta Especialidad de Oaxaca, San Bartolo Coyotepec, Oaxaca, Mexico.
  • Gil-Veloz M; Hospital Regional de Alta Especialidad del Bajío, Guanajuato, Guanajuato, Mexico.
  • Barajas-Magallón JM; Laboratorio Dipromi, Michoacán, Morelia, Mexico.
  • Aguirre-Burciaga E; Hospital Regional Delicias, Delicias, Chihuahua, Mexico.
  • López-Moreno LI; Galenia Hospital, Cancún, Quintana Roo, Mexico.
  • Martínez-Villarreal RT; Centro Universitario de Salud, Universidad Autónoma de Nuevo León. Laboratorio Vicente Guerrero, Monterrey Nuevo León, Mexico.
  • Canizales-Oviedo JL; Centro Universitario de Salud, Universidad Autónoma de Nuevo León. Laboratorio Pueblo Nuevo, Monterrey Nuevo León, Mexico.
  • Cetina-Umaña CM; Hospital Materno Infantil Morelos, Chetumal Quintana Roo, Mexico.
  • Romero-Romero D; Laboratorio de Análisis Bioquímico Clínicos "Louis Pasteur" Toluca, Estado de México, Mexico.
  • Bello-Pazos FD; Hospital H+ Querétaro, Querétaro, Querétaro, Mexico.
  • Barlandas-Rendón NRE; Laboratorio Bioclin, Chilpancingo, Guerrero, Mexico.
  • Maldonado-Anicacio JY; Hospital general de Chilpancingo, Chilpancingo, Guerrero, Mexico.
  • Bolado-Martínez E; Universidad de Sonora, Hermosillo, Sonora, Mexico.
  • Galindo-Méndez M; Laboratorios Galindo SC, Oaxaca, Oaxaca, Mexico.
  • Perez-Vicelis T; Hospital Regional "Bicentenario de la Independencia" ISSSTE, Tultitlán, Estado de México, Mexico.
  • Alavez-Ramírez N; Hospital Regional "Bicentenario de la Independencia" ISSSTE, Tultitlán, Estado de México, Mexico.
  • Méndez-Sotelo BJ; Hospital General "Dr. Manuel Gea González", Ciudad de México, Mexico.
  • Cabriales-Zavala JF; Swiss Hospital, Monterrey Nuevo león, Mexico.
  • Nava-Pacheco YC; Hospital para el Niño Poblano, San Andrés Cholula, Puebla, Mexico.
  • Moreno-Méndez MI; Laboratorios del Centro, Zamnora, Michoacán, Mexico.
  • García-Romo R; Centenario Hospital Miguel Hidalgo, Aguascalientes, Aguascalientes, Mexico.
  • Silva-Gamiño AR; Hospital Ángeles Morelia, Morelia, Michoacán, Mexico.
  • Avalos-Aguilera AM; Hospital General "Dr. Miguel Silva", Morelia, Michoacán, Mexico.
  • Santiago-Calderón MA; Hospital General de Zona No 1 Dr. Demetrio Mayoral Pardo, Oaxaca, Oaxaca, Mexico.
  • López-García M; Hospital de la Madre y Niño Guerrerense, Chilpancingo, Guerrero, Mexico.
  • Velázquez-Acosta MDC; Instituto Nacional de Cancerología, Ciudad de México, Mexico.
  • Cobos-Canul DI; Hospital General de Chetumal, Chetumal Quintana Roo, Mexico.
  • Vázquez-Larios MDR; Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, Mexico.
  • Ortiz-Porcayo AE; Hospital Regional Monterrey ISSSTE, Monterrey Nuevo León, Mexico.
PLoS One ; 16(3): e0248614, 2021.
Article in En | MEDLINE | ID: mdl-33730101
ABSTRACT

AIM:

This report presents phenotypic and genetic data on the prevalence and characteristics of extended-spectrum ß-lactamases (ESBLs) and representative carbapenemases-producing Gram-negative species in Mexico. MATERIAL AND

METHODS:

A total of 52 centers participated, 43 hospital-based laboratories and 9 external laboratories. The distribution of antimicrobial resistance data for Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae complex, Acinetobacter baumannii complex, and Pseudomonas aeruginosa in selected clinical specimens from January 1 to March 31, 2020 was analyzed using the WHONET 5.6 platform. The following clinical isolates recovered from selected specimens were included carbapenem-resistant Enterobacteriaceae, ESBL or carbapenem-resistant E. coli, and K. pneumoniae, carbapenem-resistant A. baumannii complex, and P. aeruginosa. Strains were genotyped to detect ESBL and/or carbapenemase-encoding genes.

RESULTS:

Among blood isolates, A. baumannii complex showed more than 68% resistance for all antibiotics tested, and among Enterobacteria, E. cloacae complex showed higher resistance to carbapenems. A. baumannii complex showed a higher resistance pattern for respiratory specimens, with only amikacin having a resistance lower than 70%. Among K. pneumoniae isolates, blaTEM, blaSHV, and blaCTX were detected in 68.79%, 72.3%, and 91.9% of isolates, respectively. Among E. coli isolates, blaTEM, blaSHV, and blaCTX were detected in 20.8%, 4.53%, and 85.7% isolates, respectively. For both species, the most frequent genotype was blaCTX-M-15. Among Enterobacteriaceae, the most frequently detected carbapenemase-encoding gene was blaNDM-1 (81.5%), followed by blaOXA-232 (14.8%) and blaoxa-181(7.4%), in A. baumannii was blaOXA-24 (76%) and in P. aeruginosa, was blaIMP (25.3%), followed by blaGES and blaVIM (13.1% each).

CONCLUSION:

Our study reports that NDM-1 is the most frequent carbapenemase-encoding gene in Mexico in Enterobacteriaceae with the circulation of the oxacillinase genes 181 and 232. KPC, in contrast to other countries in Latin America and the USA, is a rare occurrence. Additionally, a high circulation of ESBL blaCTX-M-15 exists in both E. coli and K. pneumoniae.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carbapenems / Gram-Negative Bacterial Infections / Beta-Lactam Resistance / Gram-Negative Bacteria / Anti-Bacterial Agents Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Mexico Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: México

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carbapenems / Gram-Negative Bacterial Infections / Beta-Lactam Resistance / Gram-Negative Bacteria / Anti-Bacterial Agents Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Mexico Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: México